Targeted Therapies for Postpartum Depression

CE / CME

Empowering Recovery: Targeted Therapies for Postpartum Depression

Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Pharmacists: 1.00 contact hour (0.1 CEUs)

Psychologists: 1.00 APA CE Credit

Social Workers: 1.00 ASWB ACE CE Credit

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: September 27, 2024

Expiration: September 26, 2025

Jennifer L Payne
Jennifer L Payne, MD

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Which of the following is one of the criteria for defining peripartum depression?

2.

Which of the following is not true for BOTH neuroactive steroids approved for the treatment of PPD (brexanolone and zuranolone)?

3.

Posttest 3: Patient Case



  • A 28-yr-old patient contacts the obstetrics clinic 3 wk after delivery with complaints of worsening depression. Has not yet been to 1-mo well-child check.

  • At age 25, she experienced a moderate MDE. She responded well to an SSRI, which was discontinued after 1 yr in remission.

  • She currently reports low mood beginning in third trimester with severe symptoms in the 3 wk since delivery. Depressive symptoms are similar to previous MDE: loss of interest, sadness, sleep disturbance, low energy, slowed movements, severe difficulty concentrating, excessive and inappropriate guilt, and thoughts of death.

  • EPDS score was 8 (#10=0) at Wk 24 of pregnancy and is 22 (#10=0) today. Functional impairment is significant for care of self, care of baby, social relationships, etc. She meets DSM-5-TR criteria for a MDE, peripartum.

What would you advise?